321
TITLE: Therapeutics for Huntington's disease: a systematic review  Full Text
AUTHORS: Mestre, TA; Ferreira, JJ; Coelho, M; Rosa, MM; Sampaio, C;
PUBLISHED: 2008, SOURCE: 12th Congress of the European-Federation-of-Neurological-Societies in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 15
INDEXED IN: WOS
322
TITLE: A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EUICD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
323
TITLE: Is treatment of cervical dystonia patients with botulinum toxin type B affected by a previous response to a botulinum toxin type A? Analysis of a long-term open-label study (AN072-401 EU/CD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Terry Germanson; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
324
TITLE: Botulinum toxin type A (Botox) versus botulinum toxin type B (Myobloc) in subjects with cervical dystonia: A comparison of the frequency of xerostomia and dysphagia (AN072-402 EU/CD)  Full Text
AUTHORS: Eric Pappert; Terry Germanson; Peter P Moore; Joaquim Ferreira;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
325
TITLE: The effects of repeated dosing of botulinum toxin type B (neurobloc (R)) in patients with cervical dystonia previously naive to botulinum toxin: An open-label extension study (AN072-402 EU/CD)  Full Text
AUTHORS: Joaquim Ferreira; Peter Moore; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
326
TITLE: A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
AUTHORS: Ferreira, JJ; Rascol, O; Poewe, W; Sampaio, C; Rocha, F; Nunes, T; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2008, SOURCE: 12th International Congress of Parkinsons Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 23, ISSUE: 1
INDEXED IN: WOS
327
TITLE: Hyposmia in G2019S LRRK2-related parkinsonism: Clinical and pathologic data
AUTHORS: Silveira-Moriyama, L; Guedes, LC; Kingsbury, A; Ayling, H; Shaw, K; Barbosa, ER; Bonifati, V; Quinn, NP; Abou-Sleiman, P; Wood, NW; Petrie, A; Sampaio, C; Ferreira, JJ; Holton, J; Revesz, T; Lees, AJ;
PUBLISHED: 2008, SOURCE: Neurology, VOLUME: 71, ISSUE: 13
INDEXED IN: CrossRef
IN MY: ORCID
328
TITLE: Hereditary neuropathies in children - The Portuguese reality  Full Text
AUTHORS: Moreno, T; Santos, M; Fonseca, M; Monteiro, J; Vieira, J; Fineza, I; Cabral, P; Ferreira, J; Moco, C; Furtado, F;
PUBLISHED: 2007, SOURCE: 12th International Congress of the World-Muscle-Society in NEUROMUSCULAR DISORDERS, VOLUME: 17, ISSUE: 9-10
INDEXED IN: WOS CrossRef
329
TITLE: Effect of nebicapone (BIA 3-202) on the the pharmacokinetics of levodopa and catechol O-methyltransferase (COMT) activity in patients with Parkinson's disease  Full Text
AUTHORS: Luis Almeida; Joaquim Ferreira; Teresa Nunes; Rita Machado; Leonel Torrao; Joana Costa; Eva Soares; Jose Rocha; Amilcar Falcao; Lyndon Wright; Patricio Soares da Silva ;
PUBLISHED: 2007, SOURCE: 75th Meeting of the British-Pharmacological-Society Clinical Pharmacology Section in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 63, ISSUE: 6
INDEXED IN: WOS
330
TITLE: Parkinson's Disease
AUTHORS: Miguel Coelho; Joaquim Ferreira; Cristina Sampaio;
PUBLISHED: 2007, SOURCE: Candelise/Evidence-based - Evidence-based Neurology: Management of Neurological Disorders
INDEXED IN: CrossRef
IN MY: ORCID
Page 33 of 38. Total results: 373.